A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

A modification layer on a surface of a ceramic substrate, includes, in parts by mass: 56 to 67.5 parts of silicon dioxide; 12 to 18 parts of aluminum oxide; and 2.8 to 5.5 parts of lithium oxide. In an embodiment, the modification layer further includes, in parts by mass: at least one of 1.8 to 2.8 parts of phosphorus pentoxide; 0.5 to 2.0 parts of calcium oxide; 0.15 to 1.5 parts of magnesium oxide; and 2.5 to 5.25 parts of barium oxide.

Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.

An electronic module for a medical device such as an inhaler is disclosed, the electronic module comprising a printed circuit board, and a damper configured to dampen energy transfer to and/or from a battery when a battery is connected to the electronic module and the electronic module is exposed to mechanical shock.

An inhaler device for pulmonary delivery of at least one substance from a drug dose cartridge to an inhaling user, including: a first conduit for conducting a carrier airflow to a proximal opening of a mouthpiece for use by the user; a holder configured to position the dose cartridge within the carrier airflow; and a second conduit for conducting a shunting airflow to the mouthpiece without passing through the dose cartridge position. In some embodiments, a controller connected to a valve controls a rate of carrier airflow, for example by controlling the shunting airflow, based on a sensor indication of airflow rate and a target airflow profile.

A polyoxymethylene polymer composition is disclosed containing a formaldehyde stabilizer package. The formaldehyde stabilizer package, which contains at least two emission control agents, dramatically and unexpectedly reduces formaldehyde emissions. The formaldehyde stabilizer package includes at least two emission control agents selected from the group of benzoguanamine compounds, a hydantoin, a substituted hydantoin, an amino acid, and an alkylene urea such as ethylene urea.

A personal vapor inhaling unit is disclosed. An electronic flameless vapor inhaler unit that may simulate a cigarette has a cavity that receives a cartridge in the distal end of the inhaler unit. The cartridge brings a substance to be vaporized in contact with a wick. A pH sensor detects a pH value of the substance to be vaporized for preventing use of an improper substance. When the pH value is confirmed, the unit is activated, and the user provides suction, the substance to be vaporized is drawn out of the cartridge, through the wick, and is atomized.

This application relates to a vaporization device and a method thereof. The vaporization device includes a housing, a heating component and a heating component top cap. The heating component has a first surface and a second surface opposite to the first surface. The first surface has an opening, the opening extends from the first surface to the second surface to form a groove, and the heating component has a heating circuit on the second surface. The housing and the heating component top cap define a storage compartment, and the storage compartment is in communication with the groove of the heating component.

This application relates to an vaporization device and a method thereof. The provided vaporization device includes a cartridge and a body. The cartridge has a housing, a heating component and a heating component base. The housing and the heating component base define an air inlet channel and an air outlet channel, and the heating component and the heating component base define a cavity. The air inlet channel is in communication with the cavity through a first communication portion, and the first communication portion is located between the heating component and the heating component base. The air outlet channel is in communication with the cavity through a second communication portion, and the second communication portion is located between the heating component and the heating component base. The body has an accommodation portion. When the cartridge and the body are removably combined, the accommodation portion covers a portion of the cartridge.

Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.